{
    "organizations": [],
    "uuid": "1b11e9e3e13e4901d4cffd04822b224b3860e01e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-protalix-announces-acceptance-of-a/brief-protalix-announces-acceptance-of-abstract-on-oprx-106as-lecture-presentation-idUSFWN1R10KD",
    "ord_in_thread": 0,
    "title": "BRIEF-Protalix Announces Acceptance Of Abstract On OPRX-106 As Lecture Presentation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 17 AM / Updated 7 minutes ago BRIEF-Protalix Announces Acceptance Of Abstract On OPRX-106 As Lecture Presentation Reuters Staff 1 Min Read March 19 (Reuters) - Protalix Biotherapeutics Inc: * PROTALIX BIOTHERAPEUTICS ANNOUNCES ACCEPTANCE OF ABSTRACT ON OPRX-106 AS A LECTURE PRESENTATION AT THE DIGESTIVE DISEASES WEEKÂ® 2018 Source text for Eikon:  ",
    "published": "2018-03-19T13:14:00.000+02:00",
    "crawled": "2018-03-19T13:27:45.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "announces",
        "acceptance",
        "abstract",
        "lecture",
        "presentation",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "protalix",
        "biotherapeutics",
        "inc",
        "protalix",
        "biotherapeutics",
        "announces",
        "acceptance",
        "abstract",
        "lecture",
        "presentation",
        "digestive",
        "disease",
        "source",
        "text",
        "eikon"
    ]
}